Neuronetics, Inc.
NGM: STIMLive Quote
📈 ZcoreAI Score
Our AI model analyzes Neuronetics, Inc.'s price action across multiple timeframes using regression channels and statistical scoring.
Get STIM Z-Score →About Neuronetics, Inc.
Healthcare
Medical Devices
Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company provides NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
📊 Fundamental Analysis
Neuronetics, Inc. demonstrates a profit margin of -26.1%, which is below the sector average, suggesting competitive pressure.
The company recently reported 85.7% revenue growth, which is well above average for the Healthcare sector.
Return on Equity (ROE) is -134.9%, which indicates that capital utilization is currently under pressure.
At a current price of $1.35, STIM currently trades near the bottom of its 52-week range (14%), indicating potential value or weakness (Range: $0.80 - $4.85).
🏥 Financial Health
🔴
Profit Margin
Weak
🔴
Debt/Equity
Elevated
✅
Revenue Growth
Excellent
🔴
Return on Equity
Weak
⚠️
Beta (Risk)
Moderate Volatility
Key Financials
Market Cap
$93.93M
Trailing P/E
--
Forward P/E
-4.22
Beta (5Y)
0.87
52W High
$4.85
52W Low
$0.80
Avg Volume
2.22M
Day High
Day Low